Philip F Halloran Selected Research

Philip F Halloran Research Topics

Disease

12	Inflammation (Inflammations) 03/2024 - 01/2002
7	Fibrosis (Cirrhosis) 01/2023 - 02/2004
6	Arteritis 01/2022 - 05/2002
5	Acute Kidney Injury (Acute Renal Failure) 12/2023 - 01/2016
5	Atrophy 01/2023 - 02/2004
3	Proteinuria 01/2021 - 06/2005
2	Hypoxia (Hypoxemia) 11/2023 - 06/2002
2	Delayed Graft Function 01/2023 - 03/2000
2	Hypertension (High Blood Pressure) 01/2019 - 10/2002
2	Renal Insufficiency (Renal Failure) 06/2010 - 10/2009
2	Necrosis 12/2003 - 05/2002
1	Left Ventricular Dysfunction 11/2023
1	Disease Progression 01/2023
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 02/2022
1	Fatty Liver 01/2022
1	Smoldering Multiple Myeloma 01/2021
1	Cicatrix (Scar) 01/2019
1	Hypertrophy 12/2015
1	Colitis 12/2014
1	Ulcerative Colitis 12/2014
1	Hypoglycemia (Reactive Hypoglycemia) 03/2012
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2012
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2010
1	Infections 09/2010
1	Neoplasms (Cancer) 09/2010
1	Heart Diseases (Heart Disease) 09/2010
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 09/2010
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2005
1	Chronic Renal Insufficiency 06/2005
1	Kidney Diseases (Kidney Disease) 04/2005
1	Edema (Dropsy) 12/2003
1	Cytomegalovirus Infections (Inclusion Disease) 09/2003
1	Drug-Related Side Effects and Adverse Reactions 10/2002
1	Brain Death (Brain Dead) 10/2002

Drug/Important Bio-Agent (IBA)

7	methoxy-morpholinyl-doxorubicinIBA 01/2023 - 01/2019
6	Cell-Free Nucleic AcidsIBA 03/2024 - 01/2022
3	Messenger RNA (mRNA)IBA 11/2023 - 12/2014
3	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 12/2003
2	Complement System Proteins (Complement)IBA 03/2020 - 01/2019
2	CreatinineIBA 06/2005 - 03/2000
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2004 - 06/2002
2	LipidsIBA 09/2003 - 10/2002
1	Endothelin-1 (Endothelin 1)IBA 11/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023
1	ArginaseIBA 11/2023
1	ChemokinesIBA 12/2022
1	Biomarkers (Surrogate Marker)IBA 12/2022
1	LigandsIBA 12/2022
1	Interleukin-6 (Interleukin 6)IBA 12/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	IsoantibodiesIBA 01/2022
1	AntigensIBA 01/2022
1	Viral AntigensIBA 11/2021
1	Viral ProteinsIBA 11/2021
1	Isoantigens (Alloantigen)IBA 11/2021
1	clazakizumabIBA 01/2021
1	daratumumabIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	SteroidsIBA 01/2021
1	Fibrillar CollagensIBA 01/2016
1	Ion Channels (Ion Channel)IBA 12/2015
1	Infliximab (Remicade)FDA Link 12/2014
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2010
1	Abatacept (Orencia)FDA Link 09/2010
1	Uric Acid (Urate)IBA 10/2009
1	VimentinIBA 06/2005
1	Cyclin-Dependent Kinase Inhibitor p16IBA 06/2005
1	Keratins (Keratin)IBA 06/2005
1	Granzymes (Granzyme)IBA 05/2004
1	PerforinIBA 05/2004
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2004
1	MHC class II transactivator proteinIBA 11/2003
1	Heme Oxygenase-1IBA 06/2002
1	Interferon-gamma (Interferon, gamma)IBA 05/2002
1	FibrinIBA 05/2002
1	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 05/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2002
1	CytokinesIBA 01/2002
1	AntibodiesIBA 03/2000

Therapy/Procedure

7	Transplantation 04/2022 - 04/2005
2	Kidney Transplantation 02/2012 - 08/2005
1	Heart-Assist Devices 02/2022
1	Liver Transplantation 01/2022
1	Therapeutics 03/2000